Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
257M
-
Number of holders
-
403
-
Total 13F shares, excl. options
-
227M
-
Shares change
-
+2.72M
-
Total reported value, excl. options
-
$21.5B
-
Value change
-
+$285M
-
Put/Call ratio
-
1
-
Number of buys
-
184
-
Number of sells
-
-197
-
Price
-
$94.68
Significant Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q2 2014
488 filings reported holding VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock as of Q2 2014.
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) has 403 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 227M shares
of 257M outstanding shares and own 88.41% of the company stock.
Largest 10 shareholders include Capital World Investors (26.4M shares), VANGUARD GROUP INC (16.7M shares), WELLINGTON MANAGEMENT CO LLP (16.5M shares), PRICE T ROWE ASSOCIATES INC /MD/ (13.9M shares), FMR LLC (13M shares), JENNISON ASSOCIATES LLC (11.9M shares), State Street Corp (9.96M shares), JPMORGAN CHASE & CO (9.64M shares), Clearbridge Investments, LLC (7.55M shares), and Ameriprise Financial Inc (7.08M shares).
This table shows the top 403 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.